Similar articles for PMID: 23922897

Year	Number of Results
1979	1
1980	1
1983	1
1985	1
1987	1
1989	1
1990	3
1991	2
1992	1
1993	3
1994	1
1995	3
1996	3
1997	3
1998	2
1999	1
2000	5
2001	3
2002	2
2003	2
2004	1
2005	7
2006	2
2007	2
2008	9
2009	1
2010	2
2011	2
2012	4
2013	6
2014	4
2015	4
2016	1
2017	7
2018	7
2019	4
2020	2
2021	5
2022	1

1

Acetaldehyde-derived advanced glycation end-products promote alcoholic liver disease.

Hayashi N, George J, Takeuchi M, Fukumura A, Toshikuni N, Arisawa T, Tsutsumi M. Hayashi N, et al. PLoS One. 2013 Jul 26;8(7):e70034. doi: 10.1371/journal.pone.0070034. Print 2013. PLoS One. 2013. PMID: 23922897 Free PMC article.

2

Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in the livers of rats with alcoholic liver disease.

Li CJ, Nanji AA, Siakotos AN, Lin RC. Li CJ, et al. Hepatology. 1997 Sep;26(3):650-7. doi: 10.1002/hep.510260317. Hepatology. 1997. PMID: 9303495

3

Cytotoxicity of acetaldehyde-derived advanced glycation end-products (AA-AGE) in alcoholic-induced neuronal degeneration.

Takeuchi M, Saito T. Takeuchi M, et al. Alcohol Clin Exp Res. 2005 Dec;29(12 Suppl):220S-4S. doi: 10.1097/01.alc.0000190657.97988.c7. Alcohol Clin Exp Res. 2005. PMID: 16385226

4

Pathogenesis of alcoholic liver disease: role of oxidative metabolism.

Ceni E, Mello T, Galli A. Ceni E, et al. World J Gastroenterol. 2014 Dec 21;20(47):17756-72. doi: 10.3748/wjg.v20.i47.17756. World J Gastroenterol. 2014. PMID: 25548474 Free PMC article. Review.

5

Neurotoxicity of acetaldehyde-derived advanced glycation end products for cultured cortical neurons.

Takeuchi M, Watai T, Sasaki N, Choei H, Iwaki M, Ashizawa T, Inagaki Y, Yamagishi S, Kikuchi S, Riederer P, Saito T, Bucala R, Kameda Y. Takeuchi M, et al. J Neuropathol Exp Neurol. 2003 May;62(5):486-96. doi: 10.1093/jnen/62.5.486. J Neuropathol Exp Neurol. 2003. PMID: 12769188

6

Co-metabolism of ethanol, ethanol-derived acetaldehyde, and 4-hydroxynonenal in isolated rat hepatocytes.

Hartley DP, Petersen DR. Hartley DP, et al. Alcohol Clin Exp Res. 1997 Apr;21(2):298-304. Alcohol Clin Exp Res. 1997. PMID: 9113267

7

Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD.

Takeuchi M, Takino JI, Sakasai-Sakai A, Takata T, Tsutsumi M. Takeuchi M, et al. Nutrients. 2017 Jun 20;9(6):634. doi: 10.3390/nu9060634. Nutrients. 2017. PMID: 28632197 Free PMC article. Review.

8

Inhibition of NF-κB activation by 4-hydroxynonenal contributes to liver injury in a mouse model of alcoholic liver disease.

Dou X, Li S, Wang Z, Gu D, Shen C, Yao T, Song Z. Dou X, et al. Am J Pathol. 2012 Nov;181(5):1702-10. doi: 10.1016/j.ajpath.2012.08.004. Epub 2012 Sep 13. Am J Pathol. 2012. PMID: 22982442 Free PMC article.

9

Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease.

Niemelä O, Parkkila S, Ylä-Herttuala S, Villanueva J, Ruebner B, Halsted CH. Niemelä O, et al. Hepatology. 1995 Oct;22(4 Pt 1):1208-14. Hepatology. 1995. PMID: 7557872

10

Hepatocyte proliferation is the possible mechanism for the transient decrease in liver injury during steatosis stage of alcoholic liver disease.

Apte UM, McRee R, Ramaiah SK. Apte UM, et al. Toxicol Pathol. 2004 Sep-Oct;32(5):567-76. doi: 10.1080/01926230490508812. Toxicol Pathol. 2004. PMID: 15603541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed